<DOC>
	<DOCNO>NCT02711215</DOCNO>
	<brief_summary>Selective serotonin reuptake inhibitor ( SSRIs ) raise serotonin ( 5-HT ) synaptic cleft current first line pharmacological antidepressive treatment . Yet , miss link first molecular step mechanism action observe clinical improvement . We determine establish framework combine genuine molecular functional imaging , i.e . hybrid pharmaco-PET/MR imaging , human serotonergic system order predict antidepressant treatment response . Objectives : 1 . To predict antidepressant treatment response data obtain use hybrid PET/MR acute pharmacological challenge . 2 . To discriminate healthy depressed subject use paradigm . 3 . To establish model connect regional change occupancy serotonin transporter ( 5-HTT ) follow citalopram infusion , change brain activation connectivity major resting-state hub network . Design : Randomized , double-blind , placebo-controlled , cross-over mono-center study . Materials method : 40 major depress ( MDD ) 40 healthy subject undergo 2 PET/MR scan 3T SIEMENS mMR Biograph scanner : 1. challenge citalopram 8mg 2. placebo ( saline ) . After structural imaging , functional MRI continuously acquire . [ 11C ] DASB apply use bolus + constant infusion paradigm probe 5-HTT binding potential monitor 5-HTT occupancy drug challenge , apply 70min , single session . Scanning terminate 80min challenge . MDD patient receive subsequent escitalopram treatment repeat evaluation response 3 month .</brief_summary>
	<brief_title>Patient Stratification Treatment Response Prediction Neuropharmacotherapy Using Hybrid Positron Emmission Tomography/Magnetic Resconance Imaging ( PET/MR )</brief_title>
	<detailed_description />
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Venlafaxine Hydrochloride</mesh_term>
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Mirtazapine</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>General health base medical history , physical examination structure clinical interview DSMIV ( SCID ) HAMDâ‰¥18 ( patient ) Willingness competence sign inform consent form Age 18 55 year Righthandedness Nonsmoker ( less 5 cigarette per week ) Any medical , psychiatric neurological illness ( MDD ) Current former psychopharmacological treatment Current former substance abuse Pregnancy Any implant stainless steel graft contraindication MRI Failure comply study protocol follow instruction investigate team Participation study involve radiation exposure past 10 year . Body mass index &lt; 17 &gt; 30 Noncaucasian</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>